Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Byggfakta in connection with the public takeover offer from Giant BidCo
Mandate

Vinge advises Byggfakta in connection with the public takeover offer from Giant BidCo

January 05, 2024 EU, Competition and Regulatory Banking and Finance

Vinge has advised Byggfakta Group Nordic HoldCo AB (publ) in connection with a public takeover offer provided by Stirling Square, TA Associates and Macquarie Capital, through Giant BidCo, to the shareholders of Byggfakta. The offer price is SEK 46 per share and values Byggfakta to approximately SEK 10.1 billion.

Vinge’s team primarily consists of Anders Strid and Edin Agic as well as Anna Palmérus (EU & Antitrust) and Albert Wållgren (Banking & Finance).

Related

Vinge advises Consolid Equity in connection with the establishment of Petra Group

 Vinge has advised Consolid Equity Investment AB ("Consolid Equity") on the acquisition of Ström & Gulliksson, one of the leading patent agencies in the Nordics. The acquisition forms part of the establishment of Petra Group, a European platform aimed at consolidating patent agencies across Europe to combine expertise and resources primarily within patents and trademarks. Consolid acts as a strategic partner in the new group.
July 08, 2026

Vinge has advised Scandic on new credit facilities with SEK 7.5 billion credit facilities

 Vinge has represented Scandic Hotels Group AB (publ) in connection with a facilities agreement for SEK 7,500,000,000 with a syndicate of banks, arranged by DNB Carnegie Investment Bank AB and Nordea Bank Abp, filial i Sverige.
July 08, 2026

Vinge has advised Vitamin Well and its majority shareholders Cinven, Bridgepoint and the founders on Vitamin Well's combination with EMPWR

 Vinge has advised Vitamin Well and its majority shareholders Cinven, the founders of Vitamin Well and Bridgepoint on Vitamin Well's acquisition of EMPWR Nutrition Group from majority seller Waterland Private Equity Investments.
July 03, 2026